GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Akorn, Inc. (AKRX) [hlAlert]

Rating:
Buy AKRX
up 228.89 %

Akorn, Inc. (AKRX) rated Buy by BofA/Merrill

Posted on: Wednesday,  Sep 26, 2012  8:25 AM ET by BofA/Merrill

BofA/Merrill rated Buy Akorn, Inc. (NASDAQ: AKRX) on 09/26/2012, when the stock price was $12.53. Since
then, Akorn, Inc. has gained 228.89% as of 01/22/2016's recent price of $41.21.
If you would have followed this BofA/Merrill's recommendation on AKRX, you would have gained 228.89% of your investment in 1213 days.

Akorn, Inc. is engaged in manufacturing and marketing diagnostic and therapeutic pharmaceuticals in specialty areas, such as ophthalmology, rheumatology, anesthesia and antidotes, among others. In addition, the Company markets and distributes vaccines purchased from outside sources. Its customers include physicians, optometrists, hospitals, wholesalers, group purchasing organizations and other pharmaceutical companies. It has a wholly owned subsidiary named Akorn (New Jersey), Inc., which operates in Somerset, New Jersey and is involved in manufacturing, product development, and administrative activities related to its ophthalmic and hospital drugs & injectables segments. The Company operates in four segments: ophthalmic, hospital drugs & injectables, biologics & vaccines and contract services.

BofA/Merrill
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/26/2012 8:25 AM Buy
None
12.53
as of 12/31/2012
1 Week up  0.98 %
1 Month down  -0.96 %
3 Months up  1.05 %
1 YTD up  6.62 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy